Cresemba (isavuconazonium sulfate) capsules — Medica
Fungal infection (systemic) in a patient with graft-versus-host disease – prophylaxis
Initial criteria
- Approve for prophylaxis of systemic fungal infection in a patient with graft-versus-host disease.
Approval duration
6 months